Quarterly Holdings Report
for
Fidelity® Small Cap Growth K6 Fund
October 31, 2023
SCPK6-NPRT1-1223
1.9884008.106
Common Stocks - 92.7% | |||
Shares | Value ($) | ||
COMMUNICATION SERVICES - 0.8% | |||
Interactive Media & Services - 0.5% | |||
Cars.com, Inc. (a) | 476,113 | 7,251,201 | |
Media - 0.2% | |||
TechTarget, Inc. (a) | 130,432 | 3,284,278 | |
Wireless Telecommunication Services - 0.1% | |||
Gogo, Inc. (a) | 221,433 | 2,325,047 | |
TOTAL COMMUNICATION SERVICES | 12,860,526 | ||
CONSUMER DISCRETIONARY - 11.6% | |||
Automobile Components - 0.6% | |||
Autoliv, Inc. | 93,552 | 8,574,041 | |
Gentherm, Inc. (a) | 37,156 | 1,494,414 | |
10,068,455 | |||
Broadline Retail - 0.3% | |||
Savers Value Village, Inc. (b) | 320,062 | 4,791,328 | |
Diversified Consumer Services - 2.1% | |||
Duolingo, Inc. (a) | 72,198 | 10,544,518 | |
Grand Canyon Education, Inc. (a) | 50,641 | 5,992,350 | |
H&R Block, Inc. | 122,048 | 5,010,070 | |
OneSpaWorld Holdings Ltd. (a) | 371,689 | 3,895,301 | |
Rover Group, Inc. Class A (a) | 1,370,152 | 8,837,480 | |
34,279,719 | |||
Hotels, Restaurants & Leisure - 1.8% | |||
Brinker International, Inc. (a) | 265,136 | 8,993,413 | |
Dutch Bros, Inc. (a)(b) | 200,065 | 4,869,582 | |
GEN Restaurant Group, Inc. (b) | 110,485 | 952,381 | |
Kura Sushi U.S.A., Inc. Class A (a)(b) | 65,851 | 3,762,726 | |
Lindblad Expeditions Holdings (a) | 115,573 | 718,864 | |
Red Rock Resorts, Inc. | 144,727 | 5,723,953 | |
SeaWorld Entertainment, Inc. (a) | 97,439 | 4,197,672 | |
29,218,591 | |||
Household Durables - 2.2% | |||
Helen of Troy Ltd. (a) | 56,524 | 5,557,440 | |
KB Home | 176,419 | 7,797,720 | |
LGI Homes, Inc. (a) | 77,007 | 7,277,932 | |
Lovesac (a)(b) | 299,788 | 4,934,510 | |
SharkNinja Hong Kong Co. Ltd. (b) | 256,823 | 10,724,928 | |
36,292,530 | |||
Leisure Products - 0.4% | |||
Games Workshop Group PLC | 20,977 | 2,517,779 | |
YETI Holdings, Inc. (a)(b) | 89,083 | 3,787,809 | |
6,305,588 | |||
Specialty Retail - 3.2% | |||
Aritzia, Inc. (a) | 192,662 | 2,996,733 | |
BARK, Inc. warrants 8/29/25 (a) | 146,166 | 10,232 | |
Boot Barn Holdings, Inc. (a) | 121,380 | 8,435,910 | |
Fanatics, Inc. Class A (a)(c)(d) | 163,048 | 12,525,347 | |
Floor & Decor Holdings, Inc. Class A (a)(b) | 47,141 | 3,884,418 | |
Murphy U.S.A., Inc. | 38,325 | 13,900,094 | |
Musti Group OYJ | 171,017 | 3,367,537 | |
thredUP, Inc. (a)(b) | 827,801 | 2,665,519 | |
Valvoline, Inc. | 141,597 | 4,201,183 | |
51,986,973 | |||
Textiles, Apparel & Luxury Goods - 1.0% | |||
Crocs, Inc. (a) | 78,017 | 6,968,478 | |
Kontoor Brands, Inc. | 215,384 | 10,004,587 | |
16,973,065 | |||
TOTAL CONSUMER DISCRETIONARY | 189,916,249 | ||
CONSUMER STAPLES - 5.0% | |||
Beverages - 1.3% | |||
Boston Beer Co., Inc. Class A (a) | 27,491 | 9,180,619 | |
The Vita Coco Co., Inc. (a) | 427,853 | 11,594,816 | |
20,775,435 | |||
Consumer Staples Distribution & Retail - 2.5% | |||
Casey's General Stores, Inc. | 8,364 | 2,274,255 | |
Performance Food Group Co. (a) | 242,587 | 14,011,825 | |
Sprouts Farmers Market LLC (a) | 347,813 | 14,615,102 | |
U.S. Foods Holding Corp. (a) | 272,357 | 10,605,582 | |
41,506,764 | |||
Food Products - 0.3% | |||
Nomad Foods Ltd. (a) | 320,922 | 4,435,142 | |
Personal Care Products - 0.9% | |||
BellRing Brands, Inc. (a) | 248,130 | 10,850,725 | |
elf Beauty, Inc. (a) | 40,500 | 3,751,515 | |
14,602,240 | |||
TOTAL CONSUMER STAPLES | 81,319,581 | ||
ENERGY - 6.2% | |||
Energy Equipment & Services - 4.2% | |||
Cactus, Inc. | 189,736 | 8,906,208 | |
Championx Corp. | 156,508 | 4,820,446 | |
Expro Group Holdings NV (a) | 348,772 | 5,493,159 | |
Liberty Oilfield Services, Inc. Class A | 598,376 | 11,788,007 | |
Patterson-UTI Energy, Inc. | 472,308 | 5,998,312 | |
TechnipFMC PLC | 794,607 | 17,099,943 | |
Weatherford International PLC (a) | 157,566 | 14,667,819 | |
68,773,894 | |||
Oil, Gas & Consumable Fuels - 2.0% | |||
Antero Resources Corp. (a) | 248,899 | 7,327,587 | |
Northern Oil & Gas, Inc. | 426,813 | 16,364,010 | |
Range Resources Corp. | 253,192 | 9,074,401 | |
32,765,998 | |||
TOTAL ENERGY | 101,539,892 | ||
FINANCIALS - 4.1% | |||
Banks - 0.5% | |||
First Interstate Bancsystem, Inc. | 97,456 | 2,248,310 | |
Pinnacle Financial Partners, Inc. | 71,895 | 4,483,372 | |
Starling Bank Ltd. Series D (a)(c)(d) | 431,700 | 1,542,647 | |
8,274,329 | |||
Capital Markets - 1.3% | |||
Houlihan Lokey | 46,075 | 4,631,459 | |
Lazard Ltd. Class A | 143,319 | 3,979,969 | |
Perella Weinberg Partners (a)(c) | 457,262 | 4,485,740 | |
StepStone Group, Inc. Class A | 258,980 | 7,329,134 | |
20,426,302 | |||
Financial Services - 1.7% | |||
Flywire Corp. (a) | 168,362 | 4,527,254 | |
Remitly Global, Inc. (a) | 620,756 | 16,716,959 | |
Walker & Dunlop, Inc. | 89,091 | 5,773,097 | |
27,017,310 | |||
Insurance - 0.6% | |||
BRP Group, Inc. (a) | 409,225 | 8,565,079 | |
Selective Insurance Group, Inc. | 17,842 | 1,857,531 | |
10,422,610 | |||
TOTAL FINANCIALS | 66,140,551 | ||
HEALTH CARE - 21.7% | |||
Biotechnology - 7.0% | |||
Absci Corp. (a)(b) | 319,351 | 415,156 | |
Acelyrin, Inc. | 61,114 | 622,446 | |
Alkermes PLC (a) | 111,509 | 2,697,403 | |
Allogene Therapeutics, Inc. (a) | 513,317 | 1,447,554 | |
ALX Oncology Holdings, Inc. (a) | 475,796 | 3,425,731 | |
Arcellx, Inc. (a) | 135,037 | 4,760,054 | |
Arrowhead Pharmaceuticals, Inc. (a) | 83,467 | 2,052,454 | |
Ascendis Pharma A/S sponsored ADR (a) | 60,534 | 5,406,292 | |
Celldex Therapeutics, Inc. (a) | 122,927 | 2,891,243 | |
Cogent Biosciences, Inc. (a) | 288,610 | 2,355,058 | |
Crinetics Pharmaceuticals, Inc. (a) | 99,346 | 2,909,844 | |
Cytokinetics, Inc. (a) | 279,155 | 9,731,343 | |
Fusion Pharmaceuticals, Inc. (a) | 616,219 | 2,840,770 | |
Immunocore Holdings PLC ADR (a) | 46,039 | 2,044,132 | |
ImmunoGen, Inc. (a) | 105,353 | 1,565,546 | |
Insmed, Inc. (a) | 95,627 | 2,396,413 | |
Janux Therapeutics, Inc. (a)(b) | 234,781 | 1,507,294 | |
Karuna Therapeutics, Inc. (a) | 7,298 | 1,215,920 | |
Keros Therapeutics, Inc. (a) | 104,413 | 2,979,947 | |
Krystal Biotech, Inc. (a) | 19,929 | 2,329,102 | |
Madrigal Pharmaceuticals, Inc. (a)(b) | 27,194 | 3,572,748 | |
Mineralys Therapeutics, Inc. (b) | 58,876 | 455,111 | |
Monte Rosa Therapeutics, Inc. (a) | 226,776 | 771,038 | |
Moonlake Immunotherapeutics (a)(b) | 51,913 | 2,689,613 | |
Morphic Holding, Inc. (a) | 128,319 | 2,559,964 | |
Nuvalent, Inc. Class A (a) | 196,230 | 10,221,621 | |
ORIC Pharmaceuticals, Inc. (a) | 239,063 | 1,601,722 | |
PepGen, Inc. (a) | 65,760 | 336,691 | |
Prelude Therapeutics, Inc. (a) | 215,872 | 364,824 | |
PTC Therapeutics, Inc. (a) | 125,799 | 2,358,731 | |
Tango Therapeutics, Inc. (a) | 462,772 | 3,887,285 | |
Tenaya Therapeutics, Inc. (a) | 291,966 | 531,378 | |
Tyra Biosciences, Inc. (a) | 236,823 | 2,747,147 | |
Vaxcyte, Inc. (a) | 188,733 | 9,078,057 | |
Vera Therapeutics, Inc. (a) | 20,656 | 215,236 | |
Vericel Corp. (a) | 149,614 | 5,263,421 | |
Verve Therapeutics, Inc. (a)(b) | 123,221 | 1,483,581 | |
Viking Therapeutics, Inc. (a)(b) | 215,065 | 2,109,788 | |
Xenon Pharmaceuticals, Inc. (a) | 118,827 | 3,683,637 | |
Zentalis Pharmaceuticals, Inc. (a) | 261,186 | 4,273,003 | |
113,798,298 | |||
Health Care Equipment & Supplies - 5.0% | |||
Axonics Modulation Technologies, Inc. (a) | 153,608 | 7,866,266 | |
Glaukos Corp. (a) | 115,369 | 7,868,166 | |
Haemonetics Corp. (a) | 156,614 | 13,348,211 | |
ICU Medical, Inc. (a)(b) | 59,657 | 5,849,965 | |
Inspire Medical Systems, Inc. (a) | 30,217 | 4,446,734 | |
Insulet Corp. (a) | 16,800 | 2,227,176 | |
Integer Holdings Corp. (a) | 69,870 | 5,671,348 | |
Lantheus Holdings, Inc. (a) | 148,190 | 9,573,074 | |
Masimo Corp. (a) | 32,413 | 2,629,667 | |
Merit Medical Systems, Inc. (a) | 33,142 | 2,278,181 | |
NeuroPace, Inc. (a)(b) | 172,742 | 1,166,009 | |
Nyxoah SA (a)(b) | 28,471 | 160,007 | |
Penumbra, Inc. (a) | 18,371 | 3,511,617 | |
PROCEPT BioRobotics Corp. (a)(b) | 182,118 | 4,878,941 | |
Pulmonx Corp. (a) | 264,224 | 2,322,529 | |
TransMedics Group, Inc. (a) | 222,792 | 8,350,244 | |
82,148,135 | |||
Health Care Providers & Services - 4.8% | |||
Acadia Healthcare Co., Inc. (a) | 154,058 | 11,324,804 | |
agilon health, Inc. (a) | 664,393 | 11,959,074 | |
HealthEquity, Inc. (a) | 218,900 | 15,690,752 | |
Molina Healthcare, Inc. (a) | 36,330 | 12,096,074 | |
Option Care Health, Inc. (a) | 166,438 | 4,615,326 | |
Privia Health Group, Inc. (a) | 283,714 | 5,963,668 | |
R1 RCM, Inc. (a)(b) | 294,541 | 3,472,638 | |
Surgery Partners, Inc. (a) | 319,906 | 7,399,426 | |
The Ensign Group, Inc. | 57,667 | 5,570,632 | |
78,092,394 | |||
Health Care Technology - 0.8% | |||
Evolent Health, Inc. (a) | 240,501 | 5,875,439 | |
Phreesia, Inc. (a) | 412,189 | 5,630,502 | |
Schrodinger, Inc. (a)(b) | 120,044 | 2,604,955 | |
14,110,896 | |||
Life Sciences Tools & Services - 1.6% | |||
10X Genomics, Inc. (a) | 89,206 | 3,147,188 | |
Medpace Holdings, Inc. (a) | 51,857 | 12,584,138 | |
Olink Holding AB ADR (a)(b) | 188,489 | 4,697,146 | |
Pacific Biosciences of California, Inc. (a) | 204,508 | 1,263,859 | |
Veterinary Emergency Group LLC Class A (a)(c)(d)(e) | 68,413 | 3,897,489 | |
25,589,820 | |||
Pharmaceuticals - 2.5% | |||
Arvinas Holding Co. LLC (a) | 49,910 | 804,549 | |
CymaBay Therapeutics, Inc. (a) | 279,264 | 4,574,344 | |
Edgewise Therapeutics, Inc. (a) | 470,739 | 3,012,730 | |
Enliven Therapeutics, Inc. (a)(b) | 215,479 | 2,669,785 | |
Ikena Oncology, Inc. (a) | 366,127 | 1,475,492 | |
Intra-Cellular Therapies, Inc. (a) | 193,474 | 9,627,266 | |
Pharvaris BV (a) | 247,130 | 4,203,681 | |
Structure Therapeutics, Inc. ADR | 70,743 | 5,256,205 | |
Terns Pharmaceuticals, Inc. (a) | 693,613 | 3,648,404 | |
Ventyx Biosciences, Inc. (a) | 181,200 | 2,612,904 | |
Verona Pharma PLC ADR (a) | 235,572 | 3,286,229 | |
41,171,589 | |||
TOTAL HEALTH CARE | 354,911,132 | ||
INDUSTRIALS - 20.9% | |||
Aerospace & Defense - 1.2% | |||
BWX Technologies, Inc. | 85,278 | 6,334,450 | |
V2X, Inc. (a) | 253,502 | 12,946,347 | |
19,280,797 | |||
Building Products - 1.7% | |||
Simpson Manufacturing Co. Ltd. | 62,973 | 8,386,744 | |
Tecnoglass, Inc. | 200,777 | 6,561,392 | |
The AZEK Co., Inc. (a) | 261,421 | 6,849,230 | |
UFP Industries, Inc. | 68,291 | 6,499,254 | |
28,296,620 | |||
Commercial Services & Supplies - 0.2% | |||
ACV Auctions, Inc. Class A (a) | 206,260 | 2,749,446 | |
Construction & Engineering - 1.1% | |||
EMCOR Group, Inc. | 43,459 | 8,980,802 | |
Sterling Construction Co., Inc. (a) | 65,674 | 4,784,351 | |
Willscot Mobile Mini Holdings (a) | 128,255 | 5,054,530 | |
18,819,683 | |||
Electrical Equipment - 3.7% | |||
Acuity Brands, Inc. | 34,774 | 5,632,345 | |
Array Technologies, Inc. (a) | 342,911 | 5,942,648 | |
Atkore, Inc. (a) | 74,913 | 9,310,188 | |
Generac Holdings, Inc. (a) | 54,607 | 4,590,810 | |
nVent Electric PLC | 176,110 | 8,476,174 | |
Prysmian SpA | 58,449 | 2,182,506 | |
Regal Rexnord Corp. | 91,280 | 10,808,465 | |
Vertiv Holdings Co. | 327,536 | 12,862,339 | |
59,805,475 | |||
Ground Transportation - 0.7% | |||
Saia, Inc. (a) | 13,948 | 5,000,219 | |
XPO, Inc. (a) | 80,277 | 6,085,799 | |
11,086,018 | |||
Machinery - 3.8% | |||
Chart Industries, Inc. (a) | 55,216 | 6,417,756 | |
Crane Co. | 93,335 | 9,084,296 | |
ESAB Corp. | 85,461 | 5,409,681 | |
Federal Signal Corp. | 196,657 | 11,413,972 | |
ITT, Inc. | 103,860 | 9,695,331 | |
Mueller Industries, Inc. | 232,256 | 8,758,374 | |
Terex Corp. | 121,097 | 5,546,243 | |
Timken Co. | 87,950 | 6,079,104 | |
62,404,757 | |||
Marine Transportation - 0.4% | |||
Kirby Corp. (a) | 78,245 | 5,844,902 | |
Professional Services - 5.3% | |||
CACI International, Inc. Class A (a) | 53,443 | 17,356,149 | |
CBIZ, Inc. (a) | 103,818 | 5,394,383 | |
ExlService Holdings, Inc. (a) | 393,305 | 10,269,194 | |
FTI Consulting, Inc. (a) | 53,074 | 11,265,487 | |
ICF International, Inc. | 65,588 | 8,311,967 | |
Insperity, Inc. | 43,133 | 4,565,197 | |
KBR, Inc. | 240,692 | 13,996,240 | |
Maximus, Inc. | 155,403 | 11,611,712 | |
WNS Holdings Ltd. sponsored ADR (a) | 84,669 | 4,599,220 | |
87,369,549 | |||
Trading Companies & Distributors - 2.8% | |||
Alligo AB (B Shares) | 316,432 | 2,483,276 | |
Applied Industrial Technologies, Inc. | 156,199 | 23,978,108 | |
FTAI Aviation Ltd. | 426,821 | 16,052,738 | |
Xometry, Inc. (a)(b) | 198,383 | 2,886,473 | |
45,400,595 | |||
TOTAL INDUSTRIALS | 341,057,842 | ||
INFORMATION TECHNOLOGY - 18.4% | |||
Communications Equipment - 0.6% | |||
Extreme Networks, Inc. (a) | 284,980 | 5,876,288 | |
Lumentum Holdings, Inc. (a) | 86,467 | 3,390,371 | |
9,266,659 | |||
Electronic Equipment, Instruments & Components - 4.2% | |||
Advanced Energy Industries, Inc. | 132,707 | 11,580,013 | |
Badger Meter, Inc. | 24,683 | 3,419,830 | |
Crane Nxt Co. | 132,141 | 6,871,332 | |
Fabrinet (a) | 99,390 | 15,405,450 | |
Insight Enterprises, Inc. (a) | 106,846 | 15,311,032 | |
TD SYNNEX Corp. | 50,118 | 4,594,818 | |
Vontier Corp. | 403,126 | 11,916,405 | |
69,098,880 | |||
IT Services - 1.2% | |||
Fastly, Inc. Class A (a) | 308,329 | 4,523,186 | |
Softcat PLC | 294,320 | 4,525,300 | |
Wix.com Ltd. (a) | 132,690 | 10,601,931 | |
19,650,417 | |||
Semiconductors & Semiconductor Equipment - 3.3% | |||
Allegro MicroSystems LLC (a) | 156,381 | 4,059,651 | |
Cirrus Logic, Inc. (a) | 106,054 | 7,098,194 | |
Impinj, Inc. (a) | 12,994 | 839,542 | |
Lattice Semiconductor Corp. (a) | 129,317 | 7,191,318 | |
MACOM Technology Solutions Holdings, Inc. (a) | 208,661 | 14,718,947 | |
Nova Ltd. (a) | 96,821 | 9,195,090 | |
Onto Innovation, Inc. (a) | 54,730 | 6,150,010 | |
Rambus, Inc. (a) | 74,777 | 4,062,634 | |
53,315,386 | |||
Software - 8.3% | |||
Alarm.com Holdings, Inc. (a) | 93,752 | 4,793,540 | |
Algolia, Inc. (a)(c)(d) | 43,269 | 526,584 | |
Alkami Technology, Inc. (a) | 313,602 | 5,629,156 | |
CommVault Systems, Inc. (a) | 26,994 | 1,764,058 | |
Confluent, Inc. (a)(b) | 267,734 | 7,740,190 | |
Convoy, Inc. warrants (a)(c)(d) | 12,642 | 0 | |
CyberArk Software Ltd. (a) | 47,828 | 7,826,574 | |
DoubleVerify Holdings, Inc. (a) | 175,423 | 4,882,022 | |
Dynatrace, Inc. (a) | 344,951 | 15,422,759 | |
Elastic NV (a) | 86,188 | 6,467,548 | |
Intapp, Inc. (a) | 305,756 | 10,456,855 | |
JFrog Ltd. (a) | 430,433 | 9,680,438 | |
Lightspeed Commerce, Inc. (a) | 264,351 | 3,293,813 | |
MicroStrategy, Inc. Class A (a)(b) | 28,688 | 12,146,212 | |
Procore Technologies, Inc. (a) | 52,400 | 3,201,116 | |
PROS Holdings, Inc. (a) | 192,049 | 5,982,326 | |
Sprout Social, Inc. (a)(b) | 273,126 | 11,820,893 | |
SPS Commerce, Inc. (a) | 26,539 | 4,255,263 | |
TECSYS, Inc. | 241,162 | 4,608,468 | |
Tenable Holdings, Inc. (a) | 363,547 | 15,308,964 | |
135,806,779 | |||
Technology Hardware, Storage & Peripherals - 0.8% | |||
IonQ, Inc. (a)(b) | 96,839 | 933,528 | |
Super Micro Computer, Inc. (a) | 49,790 | 11,923,211 | |
12,856,739 | |||
TOTAL INFORMATION TECHNOLOGY | 299,994,860 | ||
MATERIALS - 3.3% | |||
Chemicals - 1.8% | |||
Axalta Coating Systems Ltd. (a) | 170,016 | 4,459,520 | |
Cabot Corp. | 60,966 | 4,053,020 | |
Element Solutions, Inc. | 305,956 | 5,577,578 | |
Orion SA | 375,599 | 7,624,660 | |
The Chemours Co. LLC | 320,727 | 7,732,728 | |
29,447,506 | |||
Construction Materials - 0.8% | |||
Eagle Materials, Inc. | 86,191 | 13,265,657 | |
Containers & Packaging - 0.7% | |||
O-I Glass, Inc. (a) | 507,830 | 7,845,974 | |
Silgan Holdings, Inc. | 81,340 | 3,258,480 | |
11,104,454 | |||
TOTAL MATERIALS | 53,817,617 | ||
REAL ESTATE - 0.7% | |||
Equity Real Estate Investment Trusts (REITs) - 0.7% | |||
Ryman Hospitality Properties, Inc. | 131,349 | 11,243,474 | |
TOTAL COMMON STOCKS (Cost $1,490,778,175) | 1,512,801,724 | ||
Convertible Preferred Stocks - 1.3% | |||
Shares | Value ($) | ||
COMMUNICATION SERVICES - 0.1% | |||
Interactive Media & Services - 0.1% | |||
Reddit, Inc. Series F (a)(c)(d) | 46,800 | 1,457,820 | |
HEALTH CARE - 0.4% | |||
Biotechnology - 0.3% | |||
Bright Peak Therapeutics AG Series B (a)(c)(d) | 199,331 | 490,354 | |
Caris Life Sciences, Inc. Series D (a)(c)(d) | 144,435 | 605,183 | |
LifeMine Therapeutics, Inc. Series C (a)(c)(d) | 402,743 | 596,060 | |
Sonoma Biotherapeutics, Inc.: | |||
Series B (a)(c)(d) | 438,013 | 1,134,454 | |
Series B1 (a)(c)(d) | 233,603 | 686,793 | |
T-Knife Therapeutics, Inc. Series B (a)(c)(d) | 201,583 | 628,939 | |
Treeline Biosciences Series A (a)(c)(d) | 21,246 | 148,934 | |
4,290,717 | |||
Health Care Providers & Services - 0.1% | |||
Boundless Bio, Inc.: | |||
Series B (a)(c)(d) | 682,407 | 566,398 | |
Series C (c)(d) | 604,103 | 380,585 | |
946,983 | |||
Health Care Technology - 0.0% | |||
Wugen, Inc. Series B (a)(c)(d) | 59,982 | 298,111 | |
TOTAL HEALTH CARE | 5,535,811 | ||
INDUSTRIALS - 0.4% | |||
Construction & Engineering - 0.4% | |||
Beta Technologies, Inc.: | |||
Series A (a)(c)(d) | 62,752 | 5,908,101 | |
Series B, 6.00% (a)(c)(d) | 11,821 | 1,216,263 | |
7,124,364 | |||
INFORMATION TECHNOLOGY - 0.4% | |||
Communications Equipment - 0.2% | |||
Astranis Space Technologies Corp.: | |||
Series C (a)(c)(d) | 125,912 | 2,455,284 | |
Series C Prime (c)(d) | 26,805 | 522,698 | |
2,977,982 | |||
IT Services - 0.1% | |||
Yanka Industries, Inc.: | |||
Series E (a)(c)(d) | 191,029 | 1,302,818 | |
Series F (a)(c)(d) | 28,989 | 197,705 | |
1,500,523 | |||
Software - 0.1% | |||
Algolia, Inc. Series D (a)(c)(d) | 9,900 | 120,483 | |
Convoy, Inc. Series D (a)(c)(d) | 192,936 | 2 | |
Mountain Digital, Inc. Series D (a)(c)(d) | 140,383 | 1,892,363 | |
Skyryse, Inc. Series B (a)(c)(d) | 12,000 | 276,360 | |
2,289,208 | |||
TOTAL INFORMATION TECHNOLOGY | 6,767,713 | ||
TOTAL CONVERTIBLE PREFERRED STOCKS (Cost $29,175,985) | 20,885,708 | ||
Investment Companies - 3.4% | |||
Shares | Value ($) | ||
iShares Russell 2000 Growth Index ETF (b) (Cost $57,143,585) | 273,000 | 56,508,265 | |
Convertible Bonds - 0.0% | |||
Principal Amount (f) | Value ($) | ||
INFORMATION TECHNOLOGY - 0.0% | |||
Software - 0.0% | |||
Convoy, Inc. 15% 9/30/26 (c)(d) (Cost $84,195) | 84,195 | 0 | |
Money Market Funds - 7.4% | |||
Shares | Value ($) | ||
Fidelity Cash Central Fund 5.40% (g) | 38,559,881 | 38,567,593 | |
Fidelity Securities Lending Cash Central Fund 5.40% (g)(h) | 81,837,926 | 81,846,109 | |
TOTAL MONEY MARKET FUNDS (Cost $120,413,702) | 120,413,702 | ||
TOTAL INVESTMENT IN SECURITIES - 104.8% (Cost $1,697,595,642) | 1,710,609,399 |
NET OTHER ASSETS (LIABILITIES) - (4.8)% | (78,406,328) |
NET ASSETS - 100.0% | 1,632,203,071 |
Security Type Abbreviations
ETF | - | EXCHANGE-TRADED FUND |
Legend
(a) | Non-income producing |
(b) | Security or a portion of the security is on loan at period end. |
(c) | Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $43,863,515 or 2.7% of net assets. |
(d) | Level 3 security |
(e) | Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes. |
(f) | Amount is stated in United States dollars unless otherwise noted. |
(g) | Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request. |
(h) | Investment made with cash collateral received from securities on loan. |
Additional information on each restricted holding is as follows: | ||
Security | Acquisition Date | Acquisition Cost ($) |
Algolia, Inc. | 10/27/21 | 1,265,404 |
Algolia, Inc. Series D | 7/23/21 | 289,526 |
Astranis Space Technologies Corp. Series C | 3/19/21 | 2,760,108 |
Astranis Space Technologies Corp. Series C Prime | 4/05/23 | 587,591 |
Beta Technologies, Inc. Series A | 4/09/21 | 4,597,839 |
Beta Technologies, Inc. Series B, 6.00% | 4/04/22 | 1,219,573 |
Boundless Bio, Inc. Series B | 4/23/21 | 921,249 |
Boundless Bio, Inc. Series C | 4/05/23 | 422,872 |
Bright Peak Therapeutics AG Series B | 5/14/21 | 778,587 |
Caris Life Sciences, Inc. Series D | 5/11/21 | 1,169,924 |
Convoy, Inc. Series D | 10/30/19 | 2,612,353 |
Convoy, Inc. warrants | 3/24/23 | 0 |
Convoy, Inc. 15% 9/30/26 | 3/24/23 | 84,195 |
Fanatics, Inc. Class A | 8/13/20 - 3/22/21 | 2,891,600 |
LifeMine Therapeutics, Inc. Series C | 2/15/22 | 820,222 |
Mountain Digital, Inc. Series D | 11/05/21 | 3,223,938 |
Perella Weinberg Partners | 12/29/20 | 4,572,620 |
Reddit, Inc. Series F | 8/11/21 | 2,891,978 |
Skyryse, Inc. Series B | 10/21/21 | 296,160 |
Sonoma Biotherapeutics, Inc. Series B | 7/26/21 | 865,645 |
Sonoma Biotherapeutics, Inc. Series B1 | 7/26/21 | 692,516 |
Starling Bank Ltd. Series D | 6/18/21 - 4/05/22 | 824,189 |
T-Knife Therapeutics, Inc. Series B | 6/30/21 | 1,162,892 |
Treeline Biosciences Series A | 7/30/21 | 166,303 |
Veterinary Emergency Group LLC Class A | 9/16/21 - 10/31/23 | 3,615,881 |
Wugen, Inc. Series B | 7/09/21 | 465,154 |
Yanka Industries, Inc. Series E | 5/15/20 | 2,307,478 |
Yanka Industries, Inc. Series F | 4/08/21 | 924,077 |
Affiliated Central Funds
Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.
Affiliate | Value, beginning of period ($) | Purchases ($) | Sales Proceeds ($) | Dividend Income ($) | Realized Gain (loss) ($) | Change in Unrealized appreciation (depreciation) ($) | Value, end of period ($) | % ownership, end of period |
Fidelity Cash Central Fund 5.40% | 7,708,078 | 184,263,962 | 153,404,447 | 453,202 | - | - | 38,567,593 | 0.1% |
Fidelity Securities Lending Cash Central Fund 5.40% | 99,066,859 | 130,680,139 | 147,900,889 | 155,977 | - | - | 81,846,109 | 0.3% |
Total | 106,774,937 | 314,944,101 | 301,305,336 | 609,179 | - | - | 120,413,702 | |
Amounts in the dividend income column in the above table include any capital gain distributions from underlying funds.
Amounts in the dividend income column for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.
Investment Valuation
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Securities transactions are accounted for as of trade date. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.
The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:
Level 1 - Unadjusted quoted prices in active markets for identical investments
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)
Valuation techniques used to value investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For any foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.
Securities, including private placements or other restricted securities, for which observable inputs are not available are valued using alternate valuation approaches, including the market approach, the income approach and cost approach, and are categorized as Level 3 in the hierarchy. The market approach considers factors including the price of recent investments in the same or a similar security or financial metrics of comparable securities. The income approach considers factors including expected future cash flows, security specific risks and corresponding discount rates. The cost approach considers factors including the value of the security's underlying assets and liabilities.
Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. Convertible Bonds are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.
Exchange-Traded Funds (ETFs) and Exchange-Traded Notes (ETNs) are valued at their last sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day but the exchange reports a closing bid level, ETFs and ETNs are valued at the closing bid and would be categorized as Level 1 in the hierarchy. In the event there was no closing bid, ETFs and ETNs may be valued by another method that the Board believes reflects fair value in accordance with the Board's fair value pricing policies and may be categorized as Level 2 in the hierarchy.
Investments in any open-end mutual funds are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.
The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.
Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.